With fewer add-ons to buy, value has to come from the practices already owned, and buyers will want to see it practice by practice.
The acquisition playbook is running out of room. The platforms that sell well will be the ones that can show organic growth, and explain where it comes from.
For a decade, the provider platform playbook rested on acquisition: buy independent practices at a modest multiple, combine them, and sell the combined earnings at a higher one. That playbook is running out of room. Physician practice deals fell from a peak of 851 in 2021 to 105 in the first half of 2026, according to PitchBook data, and McKinsey found that private equity investment in physician assets fell by a third in 2025.
For a sponsor or a CEO, the implication is direct. With fewer add-ons to buy, value has to come from the practices already owned, and buyers will want to see it practice by practice.
Bain points to labor shortages and reimbursement pressure from public and private payers. States are adding oversight. Several now review health care transactions, and Oregon has gone furthest: its 2025 law bars management services organizations from controlling physician hiring, schedules, compensation, coding, billing policies, and payer contracts, for new arrangements since January 2026 and for existing ones from 2029.
Deals still happen, and dental, dermatology, musculoskeletal, and vision practices remain active. But McKinsey finds sponsors favoring targeted add-ons, adjacencies, and operating leverage over broad new platforms.
Bain’s 2026 health care private equity report names the new exit priorities: a track record of organic growth, repeatable playbooks for ancillaries and acquisitions, and a reputation as an employer of choice for clinicians. The buyer pool has also widened. Distributors such as Cardinal Health, Cencora, and McKesson have bought specialty platforms, and strategic buyers like these will examine organic performance closely.
A platform that cannot separate same-store growth from acquired growth will struggle to defend its value.
Headline growth can come from acquisitions, new-site ramps, added providers, or a shift in procedure mix. Each has a different value and durability.
An empty slot still carries provider, staff, and chair or room cost, and no-shows hide unused capacity.
Visits, procedures, and revenue per provider hour, site by site.
Recall and return visits for patients; retention for physicians, dentists, and advanced practice providers.
The fourth question deserves particular attention. A study by Berquist, Klarnet, and Dafny in JAMA Health Forum followed physicians at practices that private equity owners sold between 2016 and 2018. Two years after the sale, those physicians were 16.5 percentage points less likely to remain at the practice than comparable physicians elsewhere, a drop of more than a quarter in retention. They did not retire; they moved, often to larger groups. The authors suggest that retention incentives from the first deal expire at exit, and that the next owner may push harder on margins.
For a platform heading toward a sale, physician stability is a leading indicator to track now, not a surprise to discover in diligence.
AI tools for scheduling, intake, documentation, and revenue cycle are arriving in practices quickly, but they do not pay off equally everywhere. Tools that guide front-desk staff through intake and scheduling tend to help most where management is thin or turnover is high, which describes many recently acquired practices. Practices still being integrated generally benefit from guiding and offloading routine work before they attempt to redesign whole processes. In every case, the test is whether a tool moves capacity, show rates, or collections at the practice level, not whether it is in use.
The question that matters most is same-store growth, and specifically how a platform achieves it. The other three questions are its components: a practice grows organically by filling its schedules, raising provider productivity, and keeping its providers and patients. A platform that tracks headline growth without breaking it into those parts cannot tell which lever is working and which is failing, and buyers will ask.
Each acquired practice arrives with its own practice management system, its own definitions of a visit, a new patient, and a provider, and its own approach to coding and billing. The first step is a governed data foundation: a semantic layer and a shared model of practices, providers, patients, and appointments that holds across every acquisition.
The second step is economics. That means decomposing growth into same-store, acquired, de novo, and mix components; estimating what no-shows and unfilled slots cost by site; and modeling which providers are at risk of leaving and what each departure would do to revenue. A dashboard is only the last step, the place where that work becomes visible to the people who act on it.
The same foundation also changes who can do the analysis. With clear data governance in place, defining who owns each data domain, who stewards its definitions and quality, and who maintains the systems as custodian, practice and regional leaders no longer have to queue every question behind IT. A well-built semantic layer, AI tools that work against it, and the right training let operations, revenue cycle, and finance teams build the analytics they need themselves, while IT concentrates on keeping systems reliable and available.
Measurement is only the start. The analytics that pay off are the ones tied to actions the business can take. For a provider platform, those include:
Measure show rates, find what predicts a missed appointment, and score each upcoming appointment daily inside the practice management system, so front-desk staff can confirm, overbook, or fill the slot from a waitlist. We built a model of this kind for a PE-backed dental group; a pilot has shown promising early evidence.
Measure turnover, identify what precedes departures, such as changes in compensation, schedule load, or the expiry of retention terms, and set thresholds that put at-risk providers on a list regional leaders review well before an exit.
Decompose growth, find which practices are lagging and why, and direct operating attention, recruiting, or capacity to the practices where it will move results.
The platforms that sell well in this market will not be the ones that bought the most practices. They will be the ones that can show, practice by practice, that what they own is growing, full, productive, and staffed by providers who stay.
A short conversation is enough to see which of these measures your data can support today, and where the foundation needs work.
An independent read on whether a platform’s organic growth story will hold up with buyers.
Compare NotesOne governed view of practices, providers, and patients, and the economics to grow same-store revenue.
Map the Growth